|
Originally published In Press as doi:10.1074/jbc.M111399200 on January 11, 2002
J. Biol. Chem., Vol. 277, Issue 12, 9989-9996, March 22, 2002
Comparative Analysis of Cobalamin Binding Kinetics and Ligand
Protection for Intrinsic Factor, Transcobalamin, and Haptocorrin*
Sergey N.
Fedosov §,
Lars
Berglund ,
Natalya U.
Fedosova¶,
Ebba
Nexø , and
Torben E.
Petersen
From the Protein Chemistry Laboratory, Department of
Molecular and Structural Biology, University of Aarhus, Science Park,
Gustav Wieds Vej 10, 8000 Aarhus C, Denmark, the ¶ Department of
Biophysics, University of Aarhus, Ole Worms Alle 185, 8000 Aarhus C,
Denmark, and the Department of Clinical Biochemistry, AKH Aarhus
University Hospital, Nørrebrogade 44, 8000 Aarhus C, Denmark
Received for publication, November 29, 2001, and in revised form, January 7, 2002
 |
ABSTRACT |
Changes in the absorbance spectrum of
aquo-cobalamin (Cbl·OH2) revealed that its binding
to transcobalamin (TC) is followed by slow conformational
reorganization of the protein-ligand complex (Fedosov, S. N.,
Fedosova, N. U., Nexø, E., and Petersen, T. E. (2000)
J. Biol. Chem. 275, 11791-11798). Two phases were
also observed for TC when interacting with a Cbl-analogue cobinamide (Cbi), but not with other cobalamins. The slow phase had no relation to
the ligand recognition, since both Cbl and Cbi bound rapidly and in one
step to intrinsic factor (IF) and haptocorrin (HC), namely the proteins
with different Cbl specificity. Spectral transformations observed for
TC in the slow phase were similar to those upon histidine complexation
with Cbl·OH2 and Cbi. In contrast to a closed structure of TC·Cbl·OH2, the analogous IF and HC complexes
revealed accessibility of Cbl's upper face to the external reagents.
The binders decreased sensitivity of adenosyl-Cbl (Cbl·Ado) to light
in the range: free ligand, IF·, HC·, TC·Cbl·Ado. The spectrum
of TC·Cbl·Ado differed from those of IF and HC and mimicked
Cbl·Ado participating in catalysis. The above data suggest presence
of a histidine-containing cap shielding the Cbl-binding site in TC. The
cap coordinates to certain corrinoids and, possibly, produces an
incapsulated Ado-radical when Cbl·Ado is bound.
 |
INTRODUCTION |
Intrinsic factor (IF),1
transcobalamin (TC) and haptocorrin (HC) are three proteins involved in
assimilation and transport of cobalamin (Cbl) in an organism (1). They
all have extraordinary affinity to the physiologically active forms of
Cbl with Kd < 1 pM (1-4) but exhibit
different selectivity toward the nonfunctional Cbl analogues. IF and,
to some extent, TC are sensitive to variations in the structure of the
ligand, which helps these proteins to discriminate between the
physiologically active and inactive corrinoids (2, 5). On the contrary,
HC can successfully bind many defective corrinoids lacking even the
whole nucleotide moiety (2, 5). Binding to the carriers shields the
lower part of the Cbl molecule (also called -site), which contains
the nucleotide. On the contrary, the upper surface of Cbl ( -site)
with the active group is thought to be open, as judged from its
reactivity with the external compounds in the case of holo-IF and
holo-HC (6-8).
Low amounts of the Cbl-binding proteins available from the natural
sources (1, 6, 9, 10) hampered their investigations until several
binders were successfully expressed in the recombinant organisms
(11-15). The sufficient amounts of both bovine and human transcobalamin were obtained from the recombinant yeast Pichia pastoris. It allowed to establish the structure of the disulfide bridges in bovine TC (14) and investigate in detail
Cbl·OH2 binding to human TC by a stopped-flow technique
(15). It was shown that the association between TC and
Cbl·OH2 occurred in two steps, when the initial
attachment to an open conformation of the protein was followed by
transition to a closed conformation with the shielded upper face of
Cbl. As a result of this transition, cobalt-coordinated water in
Cbl·OH2 was thought to be displaced by a protein residue.
The suggestion was supported by the fact that the external compounds
coordinated to the -position of TC·Cbl·OH2 at
exceedingly slow rates. The described features, however, appeared to be
characteristic only for Cbl·OH2 interacting with TC,
whereas binding of Cbl·OH2, for instance, to HC occurred
in one step (15). Cobalamins with the tightly associated -groups
(Cbl·CN and Cbl·N3) bound both to TC and HC in one step
as well (15).
The experiments on Cbl·OH2 interaction with TC and HC
suggested a correlation between high specificity of the carrier for Cbl
and the biphasic nature of the binding reaction. In this paper we,
therefore, investigated the rapid kinetics of Cbl·OH2
binding to the most Cbl-specific protein IF. Interaction of two other ligands (Cbl·Ado and an analogue Cbi) with IF, TC, and HC was also
characterized. We found no correlation between the ligand specificity
and the biphasic kinetics of binding. Slow spectral transformations
were observed only for two ligands, Cbi (this paper) and
Cbl·OH2 (15), when interacting with TC. The character of
these changes was identical to those induced by coordination of
external histidine to Cbi or Cbl·OH2. This fact supports
the hypothesis of a cobalt-coordinated histidine residue within the complexes between TC and certain corrinoids. We also addressed the
accessibility of bound Cbl to the external cobalt-specific reagents in
different protein complexes. The results suggest that the -surface
of Cbl associated with IF or HC is moderately open, in contrast to
practically closed complex with TC. Binding of Cbl·Ado to the
proteins protected to some extent this ligand from light-induced
decomposition. In addition, the absorbance spectrum of TC·Cbl·Ado
alluded to homolytic cleavage of the carbon-cobalt bond in 10-20% of
the associated ligand molecules.
 |
EXPERIMENTAL PROCEDURES |
Materials
All salts and media components were purchased from Merck, Roche
Molecular Biochemicals, Sigma, and Beckton Dickinson. The enzymes and
kits for DNA handling were obtained from New England Biolabs,
Stratagene, and Roche Molecular Biochemicals, the kit for the PCR
reaction was from HT Biotechnology Ltd. Oligonucleotides were
synthesized by DNA technology. The employed yeast expression system was
purchased from Invitrogen. The fermentor Biostat B from B. Braun
Biotech International was employed during expression of the recombinant
proteins. Sephacryl S-200 and CM Sepharose were obtained from Amersham
Biosciences, Inc. The anti-IF serum was raised by DACO.
Methods
Preparation of the DNA Material for Expression of Human
IF--
IF-encoding fragment of DNA was produced from a gastric RNA by
the reverse transcriptase and polymerase chain reactions employing IF-specific primers with adaptors for XhoI and
NotI endonuclease sites. The obtained product was purified
and ligated to the corresponding sites in the expression plasmid
pGAPZ . The designed sequence of the fusion protein contained the
following components counting from the N terminus: a yeast secretion
signal ( -factor), the site for yeast protease Kex2, and the mature
human IF. This construction ensured cleavage of the N-terminal peptides
from the recombinant protein during its secretion: ...
LEKR STQTQ ... , IF residues are underlined.
Expression and Purification of Human IF--
The recombinant IF
was expressed according to recommendations of the manufacturer
(Invitrogen) in yeast P. pastoris (strain SMD 1168). The
constitutive promoter of glyceradehyde-3-phosphate dehydrogenase
induced the expression. The fermentation of the recombinant yeast was
carried out at 30 °C for 2 days in 1 liter of YPD medium (containing
0.5 µM Cbl·OH2) with the constant supply of
glucose. The level of oxygen and pH in the medium were maintained at
25% and 6.0, respectively. The cell-free supernatant was saturated with ammonium sulfate (520 g/liter) and centrifuged at 4,000 × g for 40 min. The pellet was dissolved in 50 ml of 0.05 M Pi buffer, pH 7.5, whereupon centrifuged once
more at 12,000 × g for 10 min. The solution was
concentrated by ultrafiltration to the volume 10-15 ml and applied to
a 250-ml Sephacryl S-200 column equilibrated with 0.1 M
Tris, 1 M NaCl, pH 7.5. The fractions with red protein were
pooled, concentrated to 5-8 ml, and subjected to repeated gel
filtration under analogous conditions. The red fractions with IF were
collected, concentrated, and stored frozen. SDS electrophoresis, staining of the gel by Coomassie, staining of the glycoproteins by PAS
method, and Western blotting were performed according to the standard procedures.
Expression and Purification of Human TC--
The recombinant TC
was produced as described in our previous publication (15).
Isolation of Human HC--
The protein was purified from human
plasma as described elsewhere (17).
Preparation of the Apo Forms of Cbl Binders--
Holo forms of
IF, TC, and HC were dialyzed against 5 M GdnHCl (IF
and TC) or 8 M GdnHCl (HC) at 30 °C for 2 days with one change. Liberation of Cbl was monitored visually. The proteins were
renaturated by overnight dialysis against 0.2 M
Pi buffer, pH 7.5, 5 °C.
Spectral Measurements--
The spectra were recorded on M350
Double Beam UV Visible Spectrophotometer (Camspec) or on the
stopped-flow equipment, see the next paragraph.
Stopped-flow Experiments on Cbl Binding--
Binding of
different corrinoids to the specific apo-proteins was followed on
DX.17MV stopped-flow spectrofluorometer (Applied Photophysics) using
difference in the absorbance spectra of the ligands in their free and
bound state, see Ref. 15. The reactions were performed in 0.2 M Pi, pH 7.5, at 20 °C.
Dissociation of the Protein-Ligand Complexes--
When
dissociation of Cbl·OH2 from its protein complexes was
investigated, the holo-protein (20 µM) was mixed with
Cbl·CN (100 µM) and incubated at room temperature for 4 days. The samples of 0.15 ml were collected at different time
intervals, suspended for 1 min with charcoal (pellet from 0.3 ml of 1%
solution), and centrifuged for 1 min at 15,000 × g.
Supernatants were centrifuged once more for 5 min. The loss of the
protein due to adsorption on charcoal did not exceed 15%. Spectra of
the protein-associated Cbls were recorded, whereupon displacement of
Cbl·OH2 by Cbl·CN was measured according to the ratios
A361/A330,
A365/A335, and A363/A330 for IF, TC, and
HC, respectively. The transition spectra were compared with those of
protein·Cbl·OH2 and protein·Cbl·CN complexes to
establish completeness of the reaction.
Dissociation of protein-Cbi complexes (20 µM) was
initiated by adding 20 µM Cbl·OH2. The
measurements were carried out as described above except for the
registration wavelengths:
A500/A580, A515/A580, and
A500/A590
for IF, TC, and HC, respectively.
Exchange of the Cobalt-coordinated Groups in the
Corrinoids--
The displacement of the cobalt-coordinated groups in
Cbi, Cbl·CN, IF·Cbl·OH2, and
HC·Cbl·OH2 (20-25 µM) by the external
ligands (CN , N and
histidine) was followed spectroscopically in 0.2 M
Pi buffer, pH 7.5, at 20 or 37 °C. Transformation of Cbl·Ado to Cbl·OH2 (either free or bound to IF, TC, and
HC) was induced by light when the sample in a quartz cuvette was placed in front of a 30 W daylight lamp at the distance of 20 cm. The changes
in absorbance were measured at 352 nm (free Cbl) and 359 nm
(protein-bound Cbl) with 1-min intervals.
Mathematical Analysis--
Fitting of the curves was performed
by a computer program for nonlinear regression
analysis2 or a program Gepasi
(18). The presented data were obtained from two to four parallel
experiments and are shown as the mean values.
 |
RESULTS |
Purification of the Cbl-binding Proteins--
Details of the
isolation procedures for human HC and human recombinant TC were
described elsewhere (15, 17). Human recombinant IF was expressed in
yeast P. pastoris and purified as described under
"Methods." The gel filtration profile of the purified recombinant IF contained one protein peak of 70 kDa saturated with
Cbl·OH2. SDS electrophoresis in the presence of a
reducing agent revealed the major protein pool of 50-55 kDa (Fig.
1, lane 2), which was reactive
toward IF-specific antibodies (Fig. 1, lane 4). The
determined N-terminal sequence was identical to human gastric IF
(STQTQS ... ). The 50-55 kDa band was not sharp, probably because
of variation in the composition of carbohydrates coupled to the protein
core of IF. The presence of carbohydrates on recombinant IF was
confirmed by PAS staining of the gel (Fig. 1, lane 3).

View larger version (92K):
[in this window]
[in a new window]
|
Fig. 1.
SDS electrophoresis of recombinant IF treated
with dithiothreitol. Lane 1, supernatant after
fermentation concentrated by ammonium sulfate precipitation (Coomassie
stained). Lane 2, purified IF (Coomassie stained).
Lane 3, purified IF (PAS stained). Lane 4,
Western blot of purified IF (polyclonal antibodies from rabbit were
generated to human gastric IF and used as the primary
antibodies).
|
|
All three Cbl binders were purified in complex with
Cbl·OH2 and preparation of apo-proteins required
treatment with GdnHCl followed by a renaturing step. The regained
binding capacity corresponded to 80-90% (TC), 60-70% (HC), and
30-40% (IF), when compared with the initial amounts of the bound
Cbl.
Changes in Cbl Absorbance Upon Its Binding to the Cbl-specific
Proteins--
Association of Cbls with IF, HC, and TC caused typical
changes in the ligand spectrum (Fig. 2)
(6, 8, 14, 15). The extinction coefficients of Cbl·OH2 in
complex with the proteins investigated are shown in Table
I. These data were obtained on the
originally purified holo forms as well as on the GdnHCl-treated, renatured and resaturated proteins. GdnHCl treatment had certain effects on the extinction coefficients. It was particularly evident for
IF where all peaks increased by 15-20% (Table I) mainly due to
intensified absorbance of the apo-protein (Fig. 2, B and
C). The corresponding changes were insignificant for
TC and practically absent for HC (Table I). The spectra of the free
ligands are given for comparison in Fig. 2D.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 2.
Spectra of different corrinoids when free or
bound to the specific proteins. The data were recorded at
20 °C, pH 7.5, with 0.5-nm steps as lines with long
dashes for IF, short dashes for HC, and solid
lines for TC. Panel A, spectra of the purified binders
(20 µM) in complex with Cbl·OH2.
Panel B, apo forms (22 µM) saturated with 20 µM Cbl·Ado. Panel C, apo forms (22 µM) saturated with 20 µM Cbi. Panel
D, spectra of the free ligands (20 µM): Cbi
(dashed line), Cbl·OH2 (line with
dash-dot pattern), Cbl·Ado (line with one dash, two dots
pattern).
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Extinction coefficients for Cbl·OH2 and its protein complexes
at pH 7.5, 37 °C
All extinction coefficients (M 1 cm 1)
were determined with S.D. between ±200 and ±600.
|
|
The most significant shifts in the absorbance spectra of all ligands
took place after their association with TC (Fig. 2, solid lines): (i) for Cbl·OH2 one can see a noticeable red
shift for all peaks (Fig. 2A); (ii) for Cbl·Ado this was a
distortion of the shape at 350-380 and 480-550 nm (Fig.
2B); (iii) for Cbi there occurred an unusual redistribution
of intensities from
A540/A580 <1 to >1
(Fig. 2C). Curiously enough, the spectrum of TC·Cbl·Ado reminded very much of those for Cbl·Ado acting as a cofactor in glutamate mutase (19) and methylmalonyl-CoA mutase (20) under steady-state conditions. On the contrary, the spectra of analogous complexes with IF and TC were similar to glutamate mutase·Cbl·Ado in rest (19).
Development of Slow Spectral Distortions--
All spectral changes
induced by the binding of Cbl·OH2, Cbl·Ado, and Cbi to
the specific proteins were accomplished in less than 1 s, except
for the pairs TC + Cbl·OH2 and TC + Cbi. Those cases
attracted our special attention.
During the binding of Cbl·OH2 to TC, the initial jump of
the -peak was followed by continual spectral changes during the next
3 min (Fig. 3A). These slow
perturbations significantly contributed to initially moderate red shift
and amplification of the -peak. The process developed exponentially
in time with the rate constant of 2.5 × 10 2
s 1, which did not differ from k+2
obtained earlier in the stopped-flow experiments at a single wavelength
(15). Increase of the temperature essentially accelerated the slow
phase but had no affect on its amplitude (at least between 20 and
37 °C).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 3.
Slow spectral changes upon the binding of
Cbl·OH2 to TC and during coordination of histidine to
IF·Cbl·OH2, HC·Cbl·OH2, and
Cbl·OH2. Apo-proteins (22 µM) were
mixed with Cbl·OH2 (20 µM), and the spectra
were recorded at 20 °C, pH 7.5, with 5-nm steps. Spectra at 1 s
were reconstructed from the stopped-flow measurements at different
wavelengths. Panel A, interaction of apo-TC with
Cbl·OH2. Panel B, reaction of
IF·Cbl·H2 (upper solid line) with 5 mM histidine. The spectral changes were recorded as
dashed lines. Panel C, reaction of
HC·Cbl·OH2 (upper solid line) with 5 mM histidine. The spectral changes were recorded as
dashed lines. Panel D, spectra of free
Cbl·OH2 (20 µM) after incubation with 5 mM aspartic acid, lysine, serine (dashed lines)
and histidine (solid line). Incubation was carried out for
2 h at 65 °C. The spectra were recorded at 20 °C with 0.5-nm
steps.
|
|
The slow decrease of absorbance for the -peak, induced by attachment
of Cbi to TC, was not very noticeable due to the originally high
absorbance of Cbi at 350-370 nm (not shown). The spectral transition
was more evident for the smaller - and -peaks (Fig. 4A), and the effect was
expressed better at 37 °C than at 20 °C. The transition was
exponential with the rate constants of 4.3 × 10 3
s 1 (20 °C) and 1.1 × 10 2
s 1 (37 °C).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
Spectral changes during the binding of Cbi to
TC, and simulation of this process by mixing free Cbi with histidine or
free Cbl with cyanide. The data were collected at 37 °C, pH
7.5, with 5-nm steps. Panel A, interaction of apo-TC (22 µM) with Cbi (20 µM). Panel B,
reaction of 20 µM Cbi with 15 mM histidine.
Positions of the spectra between 0 s and 60 s were
reconstructed from time dependence at different wavelengths. The
spectrum at histidine was deduced from the saturation curve at
0-100 mM histidine. Panel C, transition of
Cbl·CN (20 µM) to CN·Cbl·CN in the presence of 20 mM KCN. Positions of the spectra between 0 and 48 s
were reconstructed from time dependence at different wavelengths.
|
|
Imitation of the Slow Phases by Coordination of Histidine to
Cbl·OH2 and Cbi--
We have suggested earlier that the
unusual spectral behavior of Cbl·OH2 during binding to TC
may have been caused by coordination of a protein residue to cobalt
(15). The control experiment with several amino acids and free
Cbl·OH2 showed that only incubation with histidine caused
noticeable spectral response (Fig. 3D, solid line), at least under the shown conditions. This is not surprising since imidazol is a known ligand with intermediate affinity to Cbl
(21). The reaction between histidine and Cbl·OH2 was
reversible and characterized by the rate constants
k+His = 0.92 M 1
s 1 and k His = 2.2 × 10 4 s 1 (KHis= 0.24 mM) at pH 7.5 and 20 °C. At higher temperature
(37 °C) the rate coefficients increased 2.0-2.2-fold without
significant change in the equilibrium constant
KHis.
Addition of 5 mM histidine to either IF or HC complex with
Cbl·OH2 caused gradual shift of the -peak (Fig. 3,
B and C, respectively) analogous to the reaction
between histidine and free Cbl·OH2 (Fig. 3D).
All above processes were similar in their manifestation to the second
phase observed for TC + Cbl·OH2 interaction (compare Fig.
3, B and C, dashed lines, with
A). The rate coefficients of the forward reaction determined
for IF·Cbl·OH2 and HC·Cbl·OH2 were
equal to 0.44 M 1 s 1 and 0.05 M 1 s 1, respectively. The
complex TC·Cbl·OH2 did not react with histidine for at
least 2 h (not shown).
Addition of histidine to Cbi also evoked spectral changes (Fig.
4B), which testified for coordinatioin of the imidazol group to either or surface of the corrinoid (21). The recorded spectra reversibly mirrored those during displacement of the
dimethyl-benzimidazol base by cyanide: Cbl·CN + CN CN ·Cbl·CN (Fig.
4C). This may suggest attachment of histidine to the lower
axial site of Cbi. The half-maximal optical response was reached at
His = 20 mM (not shown). The apparent rate coefficient
of the process k+app = 0.021 s 1
(20 °C), k+app = 0.077 s 1
(37 °C), was, however, practically independent on histidine
concentrations at His = 5-100 mM. This means that the
velocity of conversion CN·Cbi·CN His·Cbi·CN is not limited
by attachment of histidine to cobalt, although, the details of kinetics
are not quite understood. Coordination of 15 mM histidine
to Cbi (Fig. 4B) caused the same type of the spectral
response as the binding TC + Cbi (Fig. 4A). Protection of
the TC-associated Cbi was not as good as for Cbl·OH2, and
addition of 15 mM histidine caused further spectral
transition with the velocity 14 times slower, than for free Cbi (not shown).
Binding Kinetics of Different Corrinoids--
The change in the
absorbance of Cbls and Cbi upon their attachment to the proteins was
used to monitor these processes on stopped-flow equipment. The data
depicted in Fig. 5, A-C,
represent the rapid phase of the binding. The reactions were fitted to
a bimolecular mechanism A + B C with the rate constants shown in
Table II. Ligand binding to IF was
characterized by the lowest rate constants. Association of Cbi
(corrinoid with incomplete structure) with all proteins was almost as
quick as for Cbl. No slow phase was found for IF and HC in the time
region 1-100 s (not shown). The values of
k+CblCN from the literature: 236 µM 1 s 1 for chicken HC (3) and
10 µM 1 s 1 for immobilized
bovine TC (4), are in good agreement with our results (Table II).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 5.
Binding of different corrinoids to the
specific proteins. The ligand and the protein (20 °C, pH 7.5)
were mixed in equimolar concentrations: 12 µM for
panels A-C or 40 µM for panel D. Panel A, interaction of IF with the ligands. The reactions
were followed spectroscopically at 356 nm for Cbl·OH2,
360 nm for Cbl·CN, 368 nm for Cbi, and 342 nm for Cbl·Ado.
Panel B, interaction of HC with the ligands. The reactions
were monitored at 345 nm for Cbl·Ado and 368 nm for Cbi (the optical
response at this wavelength is not maximal). Panel C,
interaction of TC with the ligands. The reactions were monitored at 361 nm for Cbl·Ado and 369 nm for Cbi. Panel D, slow phase of
interaction between TC and Cbi. The reaction was performed at 3-fold
increased concentrations and at another wavelength (580 nm) when
compared with the analogous processes shown in panel
C.
|
|
As was already mentioned, the initial attachment of Cbi to TC was
followed by a slow monomolecular reaction C D. The detected decrease of the -peak was difficult to follow at 12 µM
TC due to low response on the background of a relatively high
absorbance. Therefore, the time course of this second phase was
recorded at increased concentrations of TC and Cbi (both 40 µM) and at another wavelength corresponding to -peak
(Fig. 5D). The rate coefficients, determined from continuous
measurements, were 5.6 × 10 3 s 1
(20 °C) and 1.4 × 10 2 s 1
(37 °C). They did not differ from the data in Fig.
4A. Thorough investigation of Cbl·Ado binding to TC
at different concentrations and wavelengths did not reveal any
additional phase in this process besides the spectral changes during
the first 10 ms induced by attachment of the ligand to the protein.
Dissociation of the Ligand-Protein Complexes--
High velocity of
association between Cbi and the recombinant IF or TC raised a question
about their affinity to this analogue, since Cbi is known to be a poor
substrate for IF and TC from the natural sources (1, 2, 5, 16). We
have, therefore, characterized dissociation of the
protein·Cbl·OH2 or protein·Cbi complexes by gradual
replacement of the original ligand with added Cbl·CN or
Cbl·OH2, respectively (Fig.
6, A and B). The
process was followed in time by the spectral changes of the protein
fraction after charcoal treatment.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Liberation of Cbl·OH2 and Cbi
from the protein-ligand complexes induced by the presence of another
ligand. Panel A, displacement of Cbl·OH2
from its complex with the binders (20 µM) in the presence
of Cbl·CN (100 µM), 20 °C, pH 7.5. Samples were
taken at different time intervals and the unbound ligands were removed
by adsorption on charcoal. Spectra of the protein-associated corrinoids
were recorded and used to establish completeness of the reaction. The
calculated rate constants of dissociation were:
k CblOH = 4.2 × 10 6
s 1 and k CblCN = 9.2 × 10 6 s 1 for IF;
k CblOH = 1 × 10 7
s 1 for TC; k CblOH = 6 × 10 7 s 1 for HC (see the main text for
details). Panel B, displacement of Cbi from its complex with
the binders (20 µM) in the presence of
Cbl·OH2 (20 µM), 20 °C, pH 7.5. The rate
constants of dissociation were estimated as
k Cbi > 5 × 10 2
s 1 (IF and TC) and k Cbi < 1 × 10 5 s 1 (HC).
|
|
The data in Fig. 6A show the reaction, where a 4-fold excess
of Cbl·CN was added to the holo-proteins saturated with
Cbl·OH2. Computer simulation of the curve obtained for IF
allowed to calculate the dissociation rate constants both for
Cbl·OH2 (k CblOH = 4.2 × 10 6 s 1) and Cbl·CN
(k CblCN = 9.2 × 10 6
s 1), using the known values of
k+Cbl from Table II. The values of
k CblOH for dissociation of the corresponding
TC and HC complexes were estimated from the initial slopes
(v = k CblOH [complex]) as
1 × 10 7 s 1 and 6 × 10 7 s 1, respectively. Our previous
measurements of k CblCN for bovine and human
TCs at higher temperature (37 °C) were in the range of 1 × 10 6 to 3 × 10 6 s 1 (4,
15).
When the apo forms of recombinant IF and TC were saturated with Cbi and
exposed to equal concentration of external Cbl·OH2, the
complete substitution occurred in less than 1 min (Fig. 6B, upper curves). No detectable dissociation of HC·Cbi was
found under the same conditions (Fig. 6B, lower
curve). The rate constants of Cbi liberation were estimated as
k Cbi > 5 × 10 2
s 1 (IF, TC) and k Cbi < 1 × 10 5 s 1 (HC).
Exchange of the -Group in Cbl·OH2 Associated with
IF or HC--
It has already been shown that accessibility to the
upper face of the ligand in the TC·Cbl·OH2 complex is
hindered (15). In this assay we exposed IF (Fig.
7, A and B) and HC
(Fig. 7, C and D), saturated with
Cbl·OH2, to different concentrations of CN
or N and then followed replacement of
the original -group by changes in the absorbance. The observed reactions were practically irreversible in the case of CN
and reversible for N . The calculated rate coefficients are shown in Table III,
where the previous results for TC·Cbl·OH2 and free
Cbl·OH2 (15) are given for comparison. As one can see,
neither IF nor HC rendered significant protection against
CN . At the same time, coordination of
N to cobalt was somewhat decelerated
in both directions when compared with free Cbl·OH2.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 7.
Displacement of
-coordinated water in IF·Cbl·OH2 or
HC·Cbl·OH2 by the external reagents. The reaction
was initiated by the exposure of the holo-protein (25 µM)
to different concentrations of the substituting compound (37 °C, pH
7.5). The calculated values of the rate constants are presented in
Table III. Panel A, reaction of IF·Cbl·OH2
with cyanide: 0.1, 0.25, 0.5, 1, 2.5, 5, 10 mM
CN (curves 1-7, respectively). Panel B,
reaction of IF·Cbl·OH2 with azide: 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1, 2.5 mM
N (curves 1-8, respectively).
Panel C, reaction of HC·Cbl·OH2 with
cyanide: 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, and 10 mM
CN (curves 1-7, respectively). Panel D,
reaction of HC·Cbl·OH2 with azide: 0.025, 0.05, 0.1, 0.25, 0.5, 1, 2.5 mM N
(curves 1-7, respectively).
|
|
Specific Proteins Protect Cbl·Ado against Light-induced
Decomposition--
When Cbl binders saturated with Cbl·Ado were
exposed to light, a gradual transformation of Cbl·Ado to
Cbl·OH2 was observed (Fig.
8). The time course of these
photoactivated reactions was monitored spectroscopically and compared
with decomposition of free Cbl·Ado under analogous conditions. The
performed measurements showed a 7-, 15-, and 17-fold deceleration of
Cbl·Ado decay when the ligand was bound to IF, HC, and TC,
respectively.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Time course of the light-induced
decomposition of Cbl·Ado. From left to
right: 1, free ligand in solution, k = 0.54 min 1; 2, IF·Cbl·Ado, k = 0.078 min 1; 3, HC·Cbl·Ado, k = 0.036 min 1; 4, TC·Cbl·Ado, k = 0.032 min 1.
|
|
 |
DISCUSSION |
Binding of the Cbl molecule to the specific proteins affects its
absorbance spectrum, which turns spectroscopy to an easy and convenient
method for monitoring the protein-ligand interactions. The advantages
of the method were used for the investigation of Cbl binding to three
transporting proteins: IF, TC, and HC. Two first binders were expressed
in recombinant yeast, and HC was purified from human plasma. All
proteins were isolated as holo forms with bound Cbl·OH2
and their absorbance spectra (Fig. 2A, Table I) were typical
for the binders from other sources. GdnHCl treatment, necessary for
production of the apo-proteins, had practically no effect on the
spectra of HC and TC. At the same time, the treatment influenced IF,
and the increased absorbance of the apo-protein (Fig. 2, B
and C) resulted in artificially high extinction coefficients of the newly bound ligand (Table I). The earlier determined extinction parameters of gastric IF (8) were, nonetheless, closer to the overrated
absorbance of recombinant holo-IF after GdnHCl than to the coefficients
of "fresh" recombinant holo-IF (Table I). This observation stresses
importance of IF's history for its spectral features.
Comparison of the data in Fig. 2, A-C, with Fig.
2D showed that the most pronounced alterations in the ligand
spectra took place after binding to TC (solid lines). Thus,
the record for TC·Cbl·OH2 at pH 7.5 (Fig.
2A) demonstrated a remarkable red shift of the -peak (362 nm) and strong expression of the -peak (546 nm). This pattern
mimicked better Cbl·CN or Cbl·imidazol than Cbl·OH2
at neutral pH (21). The spectrum of another complex TC·Cbl·Ado
(Fig. 2B) was characterized by increased optical density at
350-380 and 400-450 nm as well as by decreased absorbance at 500-550
nm accompanied by separation of the individual peaks and .
Similar spectra were observed for enzyme-bound Cbl·Ado during
catalysis (19, 20), which may suggest partial homolysis of the
carbon-cobalt bond also in TC·Cbl·Ado, not trivial for a
transporting protein like TC. The complex of TC with the third ligand
Cbi (Fig. 2C) likewise revealed some redistribution of intensities between the peaks, i.e. decrease of the -peak
(578 nm) and increase of the -peak (544 nm). Analogous spectra can be observed, for instance, for Cbl during transition (base
on) ·Cbl·CN (base
off)_CN ·Cbl·CN , when cyanide and the
nucleotide base compete for the lower coordination position at cobalt
(Fig. 4C).
The peculiar spectra of the above protein-ligand complexes prompted us
to thorough investigation of the binding kinetics. Change in the
absorbance of the -peak during the ligand binding was followed by a
stopped-flow technique (Fig. 5, A-C). All ligands, including the analogue with the missing nucleotide moiety, attached rapidly and in one step to two proteins with widely different Cbl
specificity, IF and HC (Fig. 5, A and B). There
was no visible indication of any second phase during 100 s of the
binding as well, unlike the interaction between TC and
Cbl·OH2 examined earlier (15). This fact implies that the
slow phase is not an attribute of the selective recognition of Cbl but
rather a specific characteristic of TC, when interacting with certain
ligands. We doubt that presence of carbohydrates on IF and HC (1, 6)
and their absence on TC (1, 6, 15) has anything to do with the
described effects, because glycosylation does not seem to interfere
with the binding of Cbl to IF (22).
There was an interesting observation, concerning the high velocity of
association between Cbi and IF or TC. The incomplete ligand bound to
these two proteins, known to be Cbl selective (1, 2, 4, 5), almost as
quick as the ligand with the correct structure, i.e. Cbl. We
compared the association rate constants from Table II with the
collision rate constant kcoll = 5 × 109 M 1 s 1 at
20 °C estimated for a corrinoid and a binding site of appropriate geometry (23). The calculations showed that the number of the efficient
impacts varied from 2 to 20 per 1000 collisions without particular
correlation between k+Cbl and the ligand
structure. Similar rate constants found for Cbi and Cbl mean that the
Cbl-specific site is not originally tuned to any particular ligand and
can accommodate for a time being even some defective molecule. The
sensitivity of IF and TC to the substrate's geometry, and its absence
in the case of HC, was revealed only in the dissociation experiments
(Fig. 6, A and B).
Calculated values of the rate constants allowed us to make the
following estimates of Kd for
Cbl·OH2: 1 pM (IF), 0.01 pM (HC), and 0.005 pM (TC). The values for Cbi were:
Kd < 0.1 pM
(HC), Kd > 1 nM (TC and IF). The
earlier published Kd for Cbl and the specific
binders varied in the range 10 16-10 9
M (see, for review, Refs. 1-4, 8, 9, 15, and 22), which
could hardly be explained by real fluctuations of the affinity. Such a
broad dispersion was rather caused by inappropriate mathematic approach
to the case when the total concentrations of the binding site
ET and the ligand LT are close to each other
(complicated by Kd ET,
LT). Under these conditions, half-saturation would
be reached at LT(0.5) = Kd + 0.5 ET, which may represent rather concentration of the
binding site than the dissociation constant. More accurate presentation
of the results as EL versus
Lfree may also lead to an erroneous evaluation
of Kd if the reaction is almost irreversible. Under
these circumstances even a small but reproducible overestimate of
Lfree (e.g.
Lapp = Lfree + 0.05 LT) inevitably causes great overestimate of
Kd (e.g. half-saturation at
Lapp(0.5) = 1.05 Kd + 0.025 ET 0.025 ET). In such a
difficult case, determination of Kd from the ratio
of the rate constants k L/k+L may be advantageous. This statement can be illustrated by comparison of
Kd measured for chicken HC in an equilibrium assay (10 13 M) and from
k L/k+L (10 16
M) by the same authors (3).
Investigation of the rapid kinetics contributed to our understanding of
the substrate binding, although, it did not give us a clue to the
anomalous appearance of the holo-TC spectra. Therefore, the
stopped-flow experiments were repeated at different wavelength and
higher concentration of TC. They did not exhibit any second phase for
the reaction TC + Cbl·Ado but revealed it for TC + Cbi (Fig.
5D). This result demonstrated that Cbl·OH2 was
not the only corrinoid characterized by biphasic binding to TC (15).
Two atypical ligands (Cbl·OH2 and Cbi) were subjected to
thorough analysis. We have recorded deformations of the -peak for
Cbl·OH2 (Fig. 3A) and , -peaks for Cbi
(Fig. 4A) at 20 and 37 °C in an attempt to get the best
response for each corrinoid. In both cases the initial attachment of
the ligands caused slight increase and red shift of the peaks without
significant distortions of their shape (see the 1-s records in Figs.
3A and 4A). Continuation of the reactions was,
although, accompanied by more pronounced changes in the spectra,
similar to those observed during exchange of the cobalt-coordinated
groups in Cbl·OH2 and Cbi. This observation raised, in
its turn, a question about the nature of cobalt-coordinated groups in
the ligands associated with the transporting proteins.
When Cbl binds to a transporter, its lower part becomes buried inside
the protein molecule, whereas the upper part is thought to be open in
all carriers under study (7, 8, 24). At the same time, our analysis of
the -group exchange in free and bound Cbl·OH2
confirmed this statement only for IF and HC. The mechanism of the
exchange reaction for these two binders was generally the same as for
Cbl·OH2 in solution except for somewhat reduced reaction
velocities (Fig. 7, Table III). Protection of the upper surface of
Cbl·OH2 in holo-TC was much more evident. For instance, coordination of 1 mM CN or
N to holo-TC (15) was 2 orders of
magnitude slower than the same reactions with holo-IF/-HC (Fig. 7). The
accessibility of Cbl's upper plane was suggested to be hindered due to
coordination of a protein residue to cobalt at upper axial position
(15). Several amino acids have been tested on Cbl·OH2 for
their ability to cobalt coordination (Fig. 3D), but only
histidine appeared to be the sufficiently potent compound. This result
was quite anticipated, because adsorption of Cbl·OH2 on
the proteins with His residues during extraction of Cbl from biological
sources is a well known phenomenon (25). We made an attempt to imitate
the slow phase by adding histidine to holo-IF and -HC, i.e.
the proteins with the open upper surface of Cblc·OH2. The
following spectral changes reflected transition to IF·/HC·Cbl·His (Fig. 2, B and C) and bore an essential
resemblance to the second phase of Cbl·OH2 binding to TC
(Fig. 2A).
The interpretation of the spectral changes during association of Cbi
and TC seems to be more complex. It is clear that displacement of
cyanide from either lower or upper position by a histidine residue of
TC is quite feasible (compare Fig. 4, A and B).
We have also suggested that histidine coordinates to the -site of Cbi (Fig. 4, A and B) because of resemblance with
the reaction (base on) ·Cbl·CN (base off)_CN ·Cbl·CN (Fig. 4C). Some aspects remain, however, unclear. Thus, the
observed substitution of (?)-cyanide in TC·Cbi was incomplete as
followed from comparison with the Cbi spectrum at saturating histidine (Fig. 4B). This result did not match the accomplished
replacement of -water in the slow phase of the binding reaction TC + Cbl·OH2 (15). The activation energies of the second
phases for TC + Cbi (43 kJ/mol) and TC + Cbl·OH2 (120 kJ/mol) also differed quite significantly. In other words, there may be
different histidine residues involved in -substitution on
Cbl·OH2 and (?)-substitution on Cbi. Still, we cannot
exclude that a disc-shaped Cbi molecule binds to TC upside down with
the -site exposed to the same His-containing domain as the -site
of Cbl·OH2.
Another still unraveled issue is the binding of Cbl·Ado to TC. The
spectrum of the produced complex TC·Cbl·Ado was stable in time and
the associated ligand was well protected against light (Fig. 8). At the
same time, appearance of the , -peaks (Fig. 2B)
mimicked Cbl·Ado-dependent enzymes under catalysis (19, 20) when ~20% of Cbl molecules contain detached Ado· radical involved in the substrate transformation. Nonetheless, we did not find
any additional phase in the binding reaction, TC + Cbl·Ado, which
could be potentially ascribed to homolytic cleavage of the carbon-cobalt bond. The apparent absence of the second phase might be
caused by high velocity of cleavage estimated, for instance, in the
case of methylmalonyl-CoA mutase as >600 s 1 (20). The
ability of TC to induce formation of the Ado· radical may be not as
absurd as it seems to be at first sight. Thus, alignment of the pairs
(IF, TC, or HC):(methylmalonyl-CoA mutase or glutamate mutase) showed
15-19% of homology in all cases, although, at different regions.
Anyway, the unusual spectral properties of the TC·Cbl·Ado complex
require additional analysis.
The presented data throw some light upon the structure of the binding
sites of Cbl transporting proteins. One can imagine that all three
carriers are supplemented with a lid- or a cap-like structure at the
entrance to the site cavity. At the same time, development of this
structure in the Cbl transporters appears to be different. The cap in
IF does not seem to cover any appreciable part of the upper face of Cbl
and, therefore, holo-IF demonstrates quite rapid exchange of the
-groups as well as a relatively moderate protection of Cbl·Ado.
The kindred protein HC is rigged somewhat better. Its cap shields to a
certain extent the upper plane of Cbl and hinders the inwards-outwards
movements of the -coordinated groups, at least for bulky complexons.
Analogous cap in TC renders much better protection against all
substituents, and it might even produce and stabilize the Ado·
radical above the upper plain of Cbl. In addition, the protective
shield of TC is, presumably, supplemented by an active His residue,
which can coordinate to cobalt and dislodge -water in
Cbl·OH2 or (?)-cyanide in Cbi (the latter case
requires, although, additional clarification). Coordination to cobalt
at the -position locks the lid above the binding site and Cbl (but
not Cbi) becomes encapsulated inside holo-TC, with only occasional and
short-time openings to occur.
The performed investigation strengthens the view on TC as the best
protector of the associated Cbl. It also raises a question about the
role of the protective cap in stabilization and destabilization of the
cobalt-coordinated groups in TC-bound corrinoids.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 45-89-42-50-92;
Fax: 45-86-13-65-97; E-mail: snf@imsb.au.dk.
Published, JBC Papers in Press, January 11, 2002, DOI 10.1074/jbc.M111399200
2
S. N. Fedosov, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
IF, intrinsic
factor;
Cbl, cobalamin;
Cbl·OH2/·CN/·N3/·Ado, aquo/cyano/azido/5'-deoxyadenosyl cobalamin;
GdnHCl, guanidine
hydrochloride;
HC, haptocorrin;
TC, transcobalamin;
PAS, periodic
acid-Shiff reagent.
 |
REFERENCES |
| 1.
|
Nexø, E.
(1998)
in
Vitamin B12 and B12-Proteins
(Kräutler, B.
, Arigoni, D.
, and Golding, T., eds)
, pp. 461-475, Wiley-VCH, Weinheim, Germany
|
| 2.
|
Kolhouse, J. F.,
and Allen, R. H.
(1977)
J. Clin. Invest.
60,
1381-1392[Medline]
[Order article via Infotrieve]
|
| 3.
|
Marchaj, A.,
Jacobsen, D. W.,
Savon, S. R.,
and Brown, K. L.
(1995)
J. Am. Chem. Soc.
117,
11640-11646[CrossRef]
|
| 4.
|
Fedosov, S. N.,
Petersen, T. E.,
and Nexø, E.
(1995)
Biochemistry
34,
16082-16087[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Stupperich, E.,
and Nexø, E.
(1991)
Eur. J. Biochem.
199,
299-303[Medline]
[Order article via Infotrieve]
|
| 6.
|
Nexø, E.,
and Olesen, H.
(1982)
in
B12
(Dolphin, D., ed), Vol. 2
, pp. 47-85, Wiley & Sons Inc., New York
|
| 7.
|
Marques, H. M.,
Brown, K. L.,
and Jacobsen, D. W.
(1988)
J. Biol. Chem.
263,
12378-12383[Abstract/Free Full Text]
|
| 8.
|
Nexø, E.,
and Olesen, H.
(1976)
Biochim. Biophys. Acta
446,
143-150[Medline]
[Order article via Infotrieve]
|
| 9.
|
Allen, R. H.
(1975)
Prog. Hematol.
9,
57-84[Medline]
[Order article via Infotrieve]
|
| 10.
|
Fedosov, S. N.,
Petersen, T. E.,
and Nexø, E.
(1996)
Biochim. Biophys. Acta
1292,
113-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Gordon, M.,
Chokshi, H.,
and Alpers, D. H.
(1992)
Biochim. Biophys. Acta
1132,
276-283[Medline]
[Order article via Infotrieve]
|
| 12.
|
Ouadros, E. V.,
Sai, P.,
and Rothenberg, S. P.
(1993)
Blood
81,
1239-1245[Abstract/Free Full Text]
|
| 13.
|
Wen, J.,
Kinnear, M. B.,
Richardson, M. A.,
Willetts, N. S.,
Russel-Jones, G. J.,
Gordon, M. M.,
and Alpers, D. H.
(2000)
Biochim. Biophys. Acta
1490,
43-53[Medline]
[Order article via Infotrieve]
|
| 14.
|
Fedosov, S. N.,
Berglund, L.,
Nexø, E.,
and Petersen, T. E.
(1999)
J. Biol. Chem.
274,
26015-26020[Abstract/Free Full Text]
|
| 15.
|
Fedosov, S. N.,
Fedosova, N. U.,
Nexø, E.,
and Petersen, T. E.
(2000)
J. Biol. Chem.
275,
11791-11798[Abstract/Free Full Text]
|
| 16.
|
Andrews, E. R.,
Pratt, J.,
and Brown, K. L.
(1991)
FEBS Lett.
281,
90-92[Medline]
[Order article via Infotrieve]
|
| 17.
|
Nexø, E.,
Olesen, H.,
Nørredam, K.,
and Schwartz, N.
(1975)
Scand. J. Haematol.
14,
320-327[Medline]
[Order article via Infotrieve]
|
| 18.
|
Mendes, P.
(1997)
Trends Biochem. Sci.
22,
361-363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Marsh, E. N. G.,
and Ballou, D. P.
(1998)
Biochemistry
37,
11864-11878[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Padmakumar, Ru.,
Padmakumar, Ra.,
and Banerjee, R.
(1997)
Biochemistry
36,
3713-3718[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Pratt, J. M.
(1972)
Inorganic Chemistry of Vitamin B 12
, Academic Press, London
|
| 22.
|
Gordon, M. M., Hu, C.,
Chokshi, H.,
Hewitt, J. E.,
and Alpers, D. H.
(1991)
Am. J. Physiol.
260,
G736-G742[Abstract/Free Full Text]
|
| 23.
|
Eigen, M.
(1974)
in
Quantum Statistical Mechanics in the Natural Sources
(Kursunoglu, B.
, Mintz, S. L.
, and Widmayer, S. M., eds)
, pp. 37-61, Plenum Publishing Corp., New York
|
| 24.
|
Gräsbeck, R.
(1967)
Scand. J. Clin. Invest. Suppl.
95,
7-18
|
| 25.
|
Gimsing, P.,
and Nexø, E.
(1983)
in
The Cobalamins
(Hall, C. A., ed)
, pp. 7-30, Churchill Livingstone, Edinburgh, Scotland
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Waibel, H. Treichler, N. G. Schaefer, D. R. van Staveren, S. Mundwiler, S. Kunze, M. Kuenzi, R. Alberto, J. Nuesch, A. Knuth, et al.
New Derivatives of Vitamin B12 Show Preferential Targeting of Tumors
Cancer Res.,
April 15, 2008;
68(8):
2904 - 2911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Broderick, L. Alvarez, M. Balasubramanian, D. D. Belke, A. Makino, A. Chan, V. L. Woods Jr., W. H. Dillmann, V. S. Sharma, R. B. Pilz, et al.
Nitrosyl-Cobinamide, a New and Direct Nitric Oxide Releasing Drug Effective In Vivo
Experimental Biology and Medicine,
December 1, 2007;
232(11):
1432 - 1440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Broderick, M. Balasubramanian, A. Chan, P. Potluri, J. Feala, D. D. Belke, A. McCulloch, V. S. Sharma, R. B. Pilz, T. D. Bigby, et al.
The Cobalamin Precursor Cobinamide Detoxifies Nitroprusside-Generated Cyanide
Experimental Biology and Medicine,
June 1, 2007;
232(6):
789 - 798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Broderick, J. Feala, A. McCulloch, G. Paternostro, V. S. Sharma, R. B. Pilz, and G. R. Boss
The nitric oxide scavenger cobinamide profoundly improves survival in a Drosophila melanogaster model of bacterial sepsis
FASEB J,
September 1, 2006;
20(11):
1865 - 1873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Broderick, P. Potluri, S. Zhuang, I. E. Scheffler, V. S. Sharma, R. B. Pilz, and G. R. Boss
Cyanide Detoxification by the Cobalamin Precursor Cobinamide.
Experimental Biology and Medicine,
May 1, 2006;
231(5):
641 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wuerges, G. Garau, S. Geremia, S. N. Fedosov, T. E. Petersen, and L. Randaccio
Structural basis for mammalian vitamin B12 transport by transcobalamin
PNAS,
March 21, 2006;
103(12):
4386 - 4391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Broderick, V. Singh, S. Zhuang, A. Kambo, J. C. Chen, V. S. Sharma, R. B. Pilz, and G. R. Boss
Nitric Oxide Scavenging by the Cobalamin Precursor Cobinamide
J. Biol. Chem.,
March 11, 2005;
280(10):
8678 - 8685.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|